Paradigm Biopharmaceuticals Ltd. (AU:PAR)

ASX:PAR

PAR

Paradigm Biopharmaceuticals

RESEARCH TOOLSreports

Want to see AU:PAR full AI Analyst Report?

Compare Paradigm Biopharmaceuticals (PAR) vs. Competitors

41 Followers

Comparison Results

PAR

Paradigm Biopharmaceuticals

AU$0.33

AU$97.21M

-1.51

-43.94%

―

Amplia Therapeutics

AU$0.14

AU$66.70M

-3.83

136.36%

―

Actinogen Medical

AU$0.04

AU$168.67M

-4.28

74.07%

1 Buy

0 Hold

0 Sell

Moderate Buy

Dimerix Limited

AU$0.40

AU$129.09M

-5.17

-69.93%

―

Botanix Pharmaceuticals Limited

AU$0.04

AU$73.45M

-2.00

-94.19%

2 Buy

0 Hold

0 Sell

Moderate Buy

Recce Pharmaceuticals Ltd.

AU$0.41

AU$144.59M

-2.84

75.44%

―

xxxxxxxxxxxxx

PAR vs RCE

xxxxxxxxxxxxx

Performance Comparison

AU:PAR

Paradigm Biopharmaceuticals

0.19

-0.13

-40.32%

AU:ATX

Amplia Therapeutics

0.13

0.08

136.36%

AU:ACW

Actinogen Medical

0.05

0.02

74.07%

AU:DXB

Dimerix Limited

0.22

-0.40

-64.75%

AU:BOT

Botanix Pharmaceuticals Limited

0.03

-0.38

-93.33%

AU:RCE

Recce Pharmaceuticals Ltd.

0.50

0.20

66.67%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >